米国のホスピス市場規模、シェア、動向分析レポート：タイプ別、立地別、診断別、セグメント別予測、2025年～2030年

米国のホスピス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、米国のホスピス市場規模は2030年までに390億9,000万米ドルに達し、2025～2030年のCAGRは4.61％で成長すると推定されています。

成長の背景には、高齢者の増加と、この人口層における慢性疾患の有病率の増加があります。がん、認知症、心血管疾患などの慢性疾患に対する終末期ケアの需要の高まりが、産業の成長を牽引しています。NHPCOの統計によると、2020年には米国のメディケア受給者172万人が少なくとも1日以上ホスピスサービスを受けた。登録率は2019年から約6.8％増加しました。

プロバイダーの間では、新しい技術の採用が絶えず拡大しています。これには、地方へのサービスの提供や、技術によるケアへのアプローチの変革の実証も含まれます。多くのサービスプロバイダーが、遠隔医療、予測分析、バーチャルリアリティ、人工知能などの技術の導入を始めています。例えば、2023年3月、WorldViewはケアコーディネーションと提携し、自動化と患者エンゲージメントを統合することで、在宅医療とホスピスケアの提供を変革するソリューションを設計しました。

COVID-19パンデミックは、米国における産業の長期予測と運営目標に影響を与え、市場にマイナスの影響を与えました。プロバイダーは、死亡率が登録率の増加を上回ったため、2013年以来、ケアのために登録されたメディケア死亡者の最低シェアを報告しました。NHPCOのデータによると、2020年にホスピスケアを受けたメディケア死亡者の割合は約47.8%で、2019年の約51.6%よりはるかに低いです。現在、これらのセンターは、COVID-19パンデミック時に患者が対面診療を拒否したため、先進技術を採用しています。これはパンデミック後の市場成長を促進すると予想されます。

米国のホスピス市場レポートハイライト

• タイプ別では、定期的在宅ケア（RHC）セグメントが2024年の市場を独占し、92.98％の最大収益シェアを占めました。
• ホスピスセンター部門は、2024年に86.32%の最大市場シェアを占めました。
• 認知症セグメントは2024年に25.17％の最大市場シェアを占めました。これは高齢者の依存と障害によるもので、本人、家族、介護者に身体的・心理的影響が大きいです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国のホスピス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 産業の課題分析
  • 産業機会分析
• 規制枠組みと償還シナリオ
• 米国におけるホスピスケア提供の州別パフォーマンス指標
• 米国のホスピス市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国のホスピス市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 米国のホスピス市場のタイプ変動分析
• 米国のホスピス市場規模と動向分析、タイプ別、2018～2030年
• 日常の在宅ケア
• 定期的在宅ケア（RHC）
• 入院レスパイトケア
• 一般的な入院治療

第5章 米国のホスピス市場：立地別、推定・動向分析

• セグメントダッシュボード
• 米国のホスピス市場の立地変動分析
• 米国のホスピス市場規模と動向分析、立地別、2018～2030年
• ホスピスセンター
• 病院
• 在宅ホスピスケア
• 介護施設

第6章 米国のホスピス市場：診断別、推定・動向分析

• セグメントダッシュボード
• 米国のホスピス市場の診断変動分析
• 米国のホスピス市場規模と動向分析、診断別、2018～2030年
• 痴呆
• 循環器/心臓
• がん
• 呼吸器
• 脳卒中
• 慢性腎臓病
• その他

第7章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Chemed Corporation（VITAS Healthcare）
  • LHC Group, Inc.（UnitedHealth Group）
  • Amedisys
  • Gentiva
  • Brookdale Senior Living, Inc
  • Crossroads Hospice（Agape Care Group）
  • Seasons Hospice
  • Oklahoma Palliative & Hospice Care
  • Compassus
  • Chapters Health System

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. Hospice market, by type, 2018 - 2030 (USD Million)
• Table 3 U.S. Hospice market, by location, 2018 - 2030 (USD Million)
• Table 4 U.S. Hospice market, by diagnosis, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. Hospice market: Market outlook
• Fig. 5 U.S. Hospice market: Segment outlook
• Fig. 6 U.S. Hospice market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. Hospice market driver impact
• Fig. 9 U.S. Hospice market restraint impact
• Fig. 10 U.S. Hospice market: Type outlook and key takeaways
• Fig. 11 U.S. Hospice market: Type movement analysis
• Fig. 12 Routine home care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13 Continuous home care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Inpatient respite care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 General inpatient care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 U.S. Hospice market: Location outlook and key takeaways
• Fig. 17 U.S. Hospice market: Location movement analysis
• Fig. 18 Hospice center market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Home hospice care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Skilled nursing facility market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 U.S. Hospice market: Diagnosis outlook and key takeaways
• Fig. 23 U.S. Hospice market: Diagnosis movement analysis
• Fig. 24 Dementia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Circulatory/heart market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Stroke market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Chronic kidney disease market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)

U.S. Hospice Market Growth & Trends:

The U.S. hospice market size is estimated to reach USD 39.09 billion by 2030, registering to grow at a CAGR of 4.61% from 2025 to 2030 according to a new report by Grand View Research, Inc. Growth can be attributed to the growing geriatric population and the increasing prevalence of chronic disorders amid this demographic. The rising demand for end-of-life care for chronic disorders, such as cancer, dementia, and cardiovascular disease, drives the growth of the industry. According to NHPCO statistics, in 2020, 1.72 million Medicare beneficiaries in the U.S. received hospice services for at least one day or more. Enrollment rate increased by around 6.8% from 2019.

The adoption of new technologies among providers is constantly growing. This includes bringing services to rural areas and demonstrating how technology is transforming the approach to care. Many service providers have begun to deploy technology such as telemedicine, predictive analytics, virtual reality, and artificial intelligence. For instance, in March 2023, WorldView partnered with care co-ordinations to design a solution to transform home health & hospice care delivery by integrating automation and patient engagement.

The COVID-19 pandemic negatively impacted the market by affecting long-term projections and operational goals of the industry in the U.S. providers reported the lowest share of Medicare decedents enrolled for care since 2013, owing to the death rate outpacing the increase in enrollment rate. According to NHPCO data, in 2020, around 47.8% of Medicare decedents received hospice care in the U.S., much lower than around 51.6% in 2019. Currently, these centers are adopting advanced technologies due to patients refusing in-person visits during the COVID-19 pandemic. This is expected to drive market growth post-pandemic.

U.S. Hospice Market Report Highlights:

• Based on type, Routine Homecare (RHC) segment dominated the market in 2024 and accounted for the largest revenue share of 92.98%.
• The hospice center segment held the largest market share of 86.32% in 2024, owing to the various benefits offered by these facilities.
• The dementia segment held the largest market share of 25.17% in 2024, owing to the dependency and disability among the elderly, with significant physical and psychological effects on individuals, their families, and caregivers.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Type Segment
  • 1.2.2. Location Segment
  • 1.2.3. Diagnosis Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Hospice Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased awareness of end-of-life care
    • 3.2.1.2. Rising preference for home-based care
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Growing prevalence of chronic conditions
    • 3.2.1.5. Increasing number of hospice centers
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Underutilization of hospice services among population
    • 3.2.2.2. Shortage of workforce
  • 3.2.3. Industry challenges analysis
    • 3.2.3.1. Correct documentation
    • 3.2.3.2. Misconceptions & late referrals
  • 3.2.4. Industry opportunity analysis
    • 3.2.4.1. Initiatives by hospice care centers
    • 3.2.4.2. Adoption of new technologies
• 3.3. Regulatory Framework & Reimbursement Scenario
• 3.4. State-wise Performance Metrics in Hospice Care Delivery in the U.S.
• 3.5. U.S. Hospice Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
    • 3.5.2.4. Environmental Landscape
    • 3.5.2.5. Legal Landscape
    • 3.5.2.6. Social Landscape

Chapter 4. U.S. Hospice Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Hospice Market Type Movement Analysis
• 4.3. U.S. Hospice Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Routine Home Care
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Continuous Home Care
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Inpatient Respite Care
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. General Inpatient Care
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Hospice Market: Location Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Hospice Market Location Movement Analysis
• 5.3. U.S. Hospice Market Size & Trend Analysis, by Location, 2018 to 2030 (USD Million)
• 5.4. Hospice Center
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Hospital
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Home Hospice Care
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Skilled Nursing Facility
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Hospice Market: Diagnosis Model Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Hospice Market Diagnosis Movement Analysis
• 6.3. U.S. Hospice Market Size & Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
• 6.4. Dementia
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Circulatory/Heart
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Cancer
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Respiratory
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Stroke
  • 6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Chronic Kidney Disease
  • 6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Others
  • 6.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Chemed Corporation (VITAS Healthcare)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. LHC Group, Inc. (UnitedHealth Group)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Amedisys
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Gentiva
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Brookdale Senior Living, Inc
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Crossroads Hospice (Agape Care Group)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Seasons Hospice
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Oklahoma Palliative & Hospice Care
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Compassus
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Chapters Health System
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives